BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33888768)

  • 1. Characterization of the upstream and intron promoters of the gene encoding TAR DNA-binding protein.
    Hasegawa-Ogawa M; Okano HJ
    Sci Rep; 2021 Apr; 11(1):8720. PubMed ID: 33888768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
    Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
    Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation.
    Sugai A; Kato T; Koyama A; Koike Y; Konno T; Ishihara T; Onodera O
    Neurobiol Dis; 2019 Oct; 130():104534. PubMed ID: 31310801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis.
    D'Alton S; Altshuler M; Lewis J
    RNA; 2015 Aug; 21(8):1419-32. PubMed ID: 26089325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human TARDBP gene promoter.
    Baralle M; Romano M
    Sci Rep; 2021 May; 11(1):10438. PubMed ID: 34002018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1-Akt signaling pathway.
    Nishino K; Watanabe S; Shijie J; Murata Y; Oiwa K; Komine O; Endo F; Tsuiji H; Abe M; Sakimura K; Mishra A; Yamanaka K
    Acta Neuropathol Commun; 2019 Jul; 7(1):118. PubMed ID: 31345270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
    MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons.
    Maurel C; Madji-Hounoum B; Thepault RA; Marouillat S; Brulard C; Danel-Brunaud V; Camdessanche JP; Blasco H; Corcia P; Andres CR; Vourc'h P
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):149-151. PubMed ID: 28705014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred.
    Williams KL; Durnall JC; Thoeng AD; Warraich ST; Nicholson GA; Blair IP
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1286-8. PubMed ID: 19864664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
    Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
    Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
    Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related demethylation of the TDP-43 autoregulatory region in the human motor cortex.
    Koike Y; Sugai A; Hara N; Ito J; Yokoseki A; Ishihara T; Yamagishi T; Tsuboguchi S; Tada M; Ikeuchi T; Kakita A; Onodera O
    Commun Biol; 2021 Sep; 4(1):1107. PubMed ID: 34548609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS.
    Ebstein SY; Yagudayeva I; Shneider NA
    Cell Rep; 2019 Jan; 26(2):364-373.e4. PubMed ID: 30625319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP-43 subcellular distribution.
    De Marco G; Lomartire A; Calvo A; Risso A; De Luca E; Mostert M; Mandrioli J; Caponnetto C; Borghero G; Manera U; Canosa A; Moglia C; Restagno G; Fini N; Tarella C; Giordana MT; Rinaudo MT; Chiò A
    Neuropathol Appl Neurobiol; 2017 Feb; 43(2):133-153. PubMed ID: 27178390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis.
    Fratta P; Sivakumar P; Humphrey J; Lo K; Ricketts T; Oliveira H; Brito-Armas JM; Kalmar B; Ule A; Yu Y; Birsa N; Bodo C; Collins T; Conicella AE; Mejia Maza A; Marrero-Gagliardi A; Stewart M; Mianne J; Corrochano S; Emmett W; Codner G; Groves M; Fukumura R; Gondo Y; Lythgoe M; Pauws E; Peskett E; Stanier P; Teboul L; Hallegger M; Calvo A; Chiò A; Isaacs AM; Fawzi NL; Wang E; Housman DE; Baralle F; Greensmith L; Buratti E; Plagnol V; Fisher EM; Acevedo-Arozena A
    EMBO J; 2018 Jun; 37(11):. PubMed ID: 29764981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations.
    Del Bo R; Ghezzi S; Corti S; Pandolfo M; Ranieri M; Santoro D; Ghione I; Prelle A; Orsetti V; Mancuso M; Sorarù G; Briani C; Angelini C; Siciliano G; Bresolin N; Comi GP
    Eur J Neurol; 2009 Jun; 16(6):727-32. PubMed ID: 19236453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in the promoter of TARDBP in sporadic amyotrophic lateral sclerosis.
    Luquin N; Yu B; Saunderson RB; Trent RJ; Pamphlett R
    Neuromuscul Disord; 2009 Oct; 19(10):696-700. PubMed ID: 19695877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis.
    Pesiridis GS; Lee VM; Trojanowski JQ
    Hum Mol Genet; 2009 Oct; 18(R2):R156-62. PubMed ID: 19808791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.